A liquid-based cytology technique for the diagnosis of precancerous fallopian tube lesions in ovarian tumors
- Authors: Asaturova A.V.1, Sannikova M.V.1, Khabas G.N.1, Timofeeva A.V.1
-
Affiliations:
- Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
- Issue: No 5 (2017)
- Pages: 104-112
- Section: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/247969
- DOI: https://doi.org/10.18565/aig.2017.5.104-12
- ID: 247969
Cite item
Abstract
Full Text
About the authors
Alexandra Vyacheslavovna Asaturova
Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: a_asaturova@oparina4.ru
Ph.D., senior researcher, Department of Pathological Anatomy
Maya Viktorovna Sannikova
Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: m_sannikova@oparina4.ru,mvs6103@gmail.com
Ph.D
Grigory Nikolaevich Khabas
Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: g_khabas@oparina4.ru
Ph.D., head of the department of combined and complex methods of treatment of gynecological diseases
Anzhelika Vladimirovna Timofeeva
Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: v_timofeeva@oparina4.ru
Ph.D., Senior Researcher, Laboratory of Molecular Pathophysiology
References
- Siegel R., Ma J., Zou Z., Jemal A. Cancer statistics. 2014. CA Cancer J. Clin. 2014; 64(1): 9-29.
- Чиссов В.И., Старинский В.В., Петрова Г.В. ред. Злокачественные заболевания в России в 2011году (заболеваемость и смертность). М.: ФГБУ «МНИОИ им. П.А. Герцена» Минздрава России; 2013. 289с. [Chissov V.I., Starinsky V.V., Petrova G.V., ed. Malignant diseases in Russia in 2011 (morbidity and mortality). Moscow: FGBU P.A. Herzen MNIOI, Ministry of Health of Russia; 2013. 289p. (in Russian)]
- Стерджен К.М., Даффи М.Дж., Стенман У.-Х., Лилья Г., Брюннер Н., Дэниэл У. Чан Д.У. и др. Клиническое руководство Национальной академии клинической биохимии США по применению маркеров опухолей яичка, предстательной железы, прямой и ободочной кишки, молочной железы и яичников в медицинских лабораториях. Лабораторная диагностика. 2013; 3: 3-13. [Stufen K.M., Duffy M.J., Stenman U.-H., Lilya G., Brunner N., Daniel U., Chan D.U. et al. Clinical guidelines of the National Academy of Clinical Biochemistry of the United States on the use of markers of tumors of the testicle, prostate, rectum and colon, breast and ovaries in medical laboratories. Laboratornaya diagnostika. 2013; 3: 3-13. (in Russian)]
- Hoskins P., Gotlieb W. Ovarian cancer screening: UKCTOCS trial. Lancet. 2016; 387(10038): 2602-3. doi: 10.1016/S0140-6736(16)30848-0.
- Wei S.U., Li H., Zhang B. The diagnostic value of serum HE4 and CA-125 and ROMA index in ovarian cancer. Biomed. Rep. 2016; 5(1): 41-4.
- Kurman R.J., Shih I.M. The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am. J. Surg. Pathol. 2010; 34(3): 433-43. doi: 10.1097/PAS.0b013e3181cf3d79.
- Gershenson D.M. Low-grade serous carcinoma of the ovary or peritoneum. Ann. Oncol. 2016; 27(Suppl. 1): i45-i49. doi: 10.1093/annonc/mdw085.
- Karst A.M., Drapkin R. Ovarian cancer pathogenesis: a model in evolution. J. Oncol. 2010; 2010: 932371. doi: 10.1155/2010/932371.
- Powell C.B., Kenley E., Chen L.M., Crawford B., McLennan J., Zaloudek C.J. et al. Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy. J. Clin. Oncol. 2005; 23(1): 127-32.
- Finch A., Shaw P., Rosen B., Murphy J., Narod S.A., Colgan T.J. Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers. Gynecol. Oncol. 2006; 100(1): 58-64.
- Ren Z., Zhang Y., Yang H., Zhu L., Maeda D., Takazawa Y. Liquid-based cytology aids in primary fallopian tube cancer diagnosis. J. Zhejiang Univ. Sci B. 2009; 10(8): 635-8.
- Maeda D., Takazawa Y., Ota S., Takeuchi Y., Seta A., Nakagawa S. et al. Bilateral microscopic adenocarcinoma of the fallopian tubes detected by an endometrial cytologic smear. Int. J Gynecol. Pathol. 2010; 29(3): 273-7.
- Minato H., Shimizu M., Hirokawa M., Fujiwara K., Kohno I., Manabe T. Adenocarcinoma in situ of the fallopian tube. A case report. Acta Cytol. 1998; 42(6): 1455-7.
- Dudkiewicz J. Quantitative and qualitative changes of epithelial cells of fallopian tubes in women according to the phase of menstrual cycle. A cytologic study. Acta Cytol. 1970; 14(8): 531-7.
- Dhanani M., Nassar A., Dinh T. Classification of fallopian tube cytology sampling to develop a model for future peritoneal and ovarian cancer screening. J. Am. Soc. Cytopathol. 2014; 3(5): S35-6. doi: 10.1016/j.jasc.2014.09.076.
- Lum D., Guido R., Rodriguez E., Lee T., Mansuria S., D'Ambrosio L., Austin R.M. Brush cytology of the fallopian tube and implications in ovarian cancer screening. J. Minim. Invasive Gynecol. 2014; 21(5): 851-6. doi: 10.1016/j. jmig.2014.03.017.
- Herzberg A.J., Raso D.S., Silverman J.F. Color atlas of normal cytology. Churchill Livingstone; 1999.
- Haeusler G., Tempfer C., Lehner R., Sam C., Kainz C. Fallopian tissue sampling with a cytobrush during hysteroscopy: a new approach for detecting tubal infection. Fertil. Steril. 1997; 67(3): 580-2.
- Matsushima T., Kaseki H., Ishihara K., Araki T. J Assessment of fallopian tube cytology for the diagnosis of endometriosis and hydrosalpinx. Nippon Med. Sch. 2002; 69(5): 445-50.
- Mulvany N.J., Arnstein M., Ostör A.G. Fallopian tube cytology: a histocorrelative study of 150 washings. Diagn. Cytopathol. 1997; 16(6): 483-8.
- Kurman R.J., Shih Ie.M. Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm. Hum. Pathol. 2011; 42(7): 918-31. doi: 10.1016/j.humpath.2011.03.003.
- Асатурова А.В., Коган Е.А., Ежова Л.С., Жарков Н.В., Файзуллина Н.М., Хабас Г.Н. Папиллярная гиперплазия маточной трубы: сочетание с серозными пограничными опухолями яичника и молекулярно-биологическая характеристика. Акушерство и гинекология. 2015; 11: 58-64. [Asaturova A.V., Kogan E.A., Ezhova L.S., Zharkov N.V., Faizullina N.M., Khabas G.N. Papillary tubal hyperplasia: Concurrence with serous borderline ovarian tumors and molecular biological characteristics. Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2015; 11: 58-64. (in Russian)]
- Kuhn E., Kurman R.J., Soslow R.A., Han G., Sehdev A.S., Morin P.J. et al. The diagnostic and biological implications of laminin expression in serous tubal intraepithelial carcinoma. Am. J. Surg. Pathol. 2012; 36(12): 1826-34. doi: 10.1097/PAS.0b013e31825ec07a.
- Matjusaitis M., Chin G., Sarnoski E.A., Stolzing A. Biomarkers to identify and isolate senescent cells. Ageing Res. Rev. 2016; 29: 1-12.
- Vang R., Visvanathan K., Gross A., Maambo E., Gupta M., Kuhn E. et al. Validation of an algorithm for the diagnosis of serous tubal intraepithelial carcinoma. Int. J. Gynecol. Pathol. 2012; 31(3): 243-53. doi: 10.1097/PGP.0b013e31823b8831.
- Mahe E., Tang S., Deb P., Sur M., Lytwyn A., Daya D. Do deeper sections increase the frequency of detection of serous tubal intraepithelial carcinoma (STIC) in the „sectioning and extensively examining the fimbriated end” (SEE-FIM) protocol? Int. J. Gynecol. Pathol. 2013; 32(4): 353-7. doi: 10.1097/ PGP.0b013e318264ae09.